Somnus
ID: 353867Type: Posted
Overview

Buyer

DARPA - Biological Technologies Office (DOD-DARPA-BTO)

Eligible Applicants

Others

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Other

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Defense Advanced Research Projects Agency (DARPA) is inviting proposals for the Somnus research initiative, which aims to explore the molecular mechanisms linking gut microbiome interactions and the restorative effects of sleep on cognitive performance. This opportunity is open to all responsible sources capable of meeting the government's needs, with a focus on identifying specific intestinal regions relevant to sleep and immune responses, while adhering to ethical guidelines and providing detailed experimental designs. Up to $2 million in funding is available for individual projects lasting up to 18 months, with proposals due by June 17, 2024. Interested applicants can reach out to Matthew Pava at Somnus@darpa.mil for further information and clarification.

    Point(s) of Contact
    Files
    Title
    Posted
    Amendment 1 to DARPARA2402 introduces a Frequently Asked Questions (FAQ) document relevant to the Somnus Research Announcement (RA). This amendment is limited in scope, as it specifies that no other modifications have been made to the original declaration. The inclusion of the FAQ suggests a desire to clarify processes or expectations associated with the research announcement, likely aimed at supporting potential applicants or stakeholders involved in the grant and proposal processes. By addressing common inquiries, the amendment aims to facilitate a smoother interaction with the RFP and grant guidelines. Overall, this document reflects the government’s effort to enhance transparency and accessibility in the funding and research application process.
    The DARPA Somnus program aims to investigate the effects of sleep deprivation on molecular pathways intertwining the gut and brain. Up to $2 million in funding will be allocated for individual projects lasting up to 18 months, with no limit on collaboration from various institutions, although clear explanations of cooperative efforts are necessary. The Current RA is not a follow-on from the previous Somnus BAA; no awards were made from that. Human research isn’t permitted, and proposals must clarify the intestinal regions chosen for study, based on their relevance to sleep and immune responses. Proposers should detail the number of biospecimens, experimental designs, and ensure adherence to ethical guidelines. Automated methods of sleep deprivation are acceptable, but proposals must include a gold-standard control. Required specimens include blood and fecal samples at various checkpoints, with emphasis on securing sufficient volumes for analyses. The project discourages the use of sugar-based rewards in behavioral tasks. Additionally, alternative data collection methods and analyses outside DARPA specifications are allowed as long as the total costs remain within the funding limit. This structured inquiry is pivotal for understanding host-microbiome interactions under sleep deprivation conditions.
    Similar Opportunities
    Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Interventions to Reduce Sleep Health Disparities," aimed at supporting innovative projects that promote sleep health and address sleep-related health inequalities. This initiative invites applications for non-pharmacological interventions targeting diverse populations experiencing health disparities, particularly focusing on improving sleep health among historically marginalized groups, including racial and ethnic minorities and low socioeconomic populations. The funding opportunity emphasizes the importance of understanding the multi-level determinants affecting sleep health disparities and aims to enhance overall health equity in the U.S. Interested applicants can find more information and submit proposals starting January 5, 2025, with a closing date for applications on September 7, 2027. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-330.html.
    Biological Technologies
    DARPA - Biological Technologies Office
    The Defense Advanced Research Projects Agency (DARPA) is soliciting proposals for its Biological Technologies Office (BTO) under the Broad Agency Announcement (BAA) HR001126S0003, aimed at leveraging biological properties and processes to enhance the protection of the nation's warfighters. Proposals should focus on transformative solutions in areas such as artificial intelligence/machine learning applications in biological data, combat casualty care, human performance optimization, and biodefense, explicitly excluding incremental improvements to existing technologies. This opportunity is critical for advancing national security through innovative research and development, with proposals accepted on a rolling basis until September 30, 2026. Interested applicants can reach out to the BAA Coordinator at BTOBAA2026@darpa.mil for further information, and must adhere to specific submission guidelines, including the requirement to submit an abstract prior to full proposal submission.
    Funding Opportunity Announcement for Impact of Environmental Exposures on Gut-Brain Signaling in Neurological Conditions (R01)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for research on the impact of environmental exposures on gut-brain signaling in neurological conditions through the R01 grant mechanism. This initiative aims to enhance understanding of the gut microbiome-brain axis to develop intervention strategies for neurological diseases influenced by environmental factors, including mental health disorders and neurodegenerative conditions like Parkinson's and Alzheimer's diseases. The program is expected to allocate approximately $4 million across eight awards, with applications anticipated to open following the publication of a Notice of Funding Opportunity (NOFO) in late October 2025, and the estimated project start date is set for July 1, 2026. Interested researchers are encouraged to contact Dr. Anika L. Dzierlenga at anika.dzierlenga@nih.gov or call 984-287-3125 for further information.
    Tactical Behaviors for Autonomous Maneuver
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a funding opportunity through the Tactical Behaviors for Autonomous Maneuver Collaborative Research Program (TBAM-CRP) aimed at enhancing the capabilities of robotic and autonomous systems (RAS) for military operations in complex environments. This program seeks proposals that develop coordinated and adaptive behaviors for small groups of autonomous agents, focusing on innovative maneuver tactics and strategies to operate effectively in multi-domain operations against peer adversaries. The TBAM-CRP is critical for advancing military capabilities, leveraging new technologies in robotics and autonomous systems to improve situational awareness and operational effectiveness on the battlefield. Interested applicants, including institutions of higher education and for-profit organizations, are invited to submit proposals by April 24, 2024, with funding amounts ranging from $100,000 to $2.3 million available per award. For further inquiries, applicants can contact Christopher D. Justice at usarmy.adelphi.devcom-arl.mbx.tbam-crp-questions@army.mil.
    Defense Sciences Office (DSO) Office-wide BAA
    DARPA - Defense Sciences Office
    The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals through its Defense Sciences Office (DSO) under the Broad Agency Announcement (BAA) HR001125S0013, aimed at advancing national security through revolutionary scientific and technological developments. Proposals should focus on groundbreaking research that leads to significant advancements rather than incremental improvements, covering areas such as materials, manufacturing, sensing, and intelligent systems. This initiative is crucial for fostering collaboration between government and private entities to enhance national security capabilities. Interested applicants can submit proposals until June 2, 2026, and are encouraged to contact the BAA Coordinator at HR001125S0013@darpa.mil for further information.
    Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)" aimed at advancing innovative research into precision probiotic interventions. This initiative seeks applications that will investigate person-specific factors influencing probiotic responses, such as microbiome composition, age, sex, genetic background, and lifestyle, to identify subgroups that may benefit from tailored probiotic treatments. The funding is crucial for addressing variability in human responses to probiotics and aims to enhance health outcomes through targeted interventions. Applicants can request up to $350,000 per year for a maximum of four years, with the application deadline set for June 2, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-239.html.
    Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)" aimed at supporting innovative mechanistic research to develop precision probiotic interventions. This initiative seeks to identify person-specific biological features that influence probiotic responses, thereby enhancing clinical outcomes and addressing the variability in individual responses to probiotics. The funding, which can reach a maximum of $350,000 annually over a combined duration of up to five years, is open to a diverse range of applicants, including educational institutions and nonprofit organizations, while excluding foreign entities. Interested applicants must submit their proposals by June 2, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has announced a Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development. This opportunity invites unrestricted applicants to submit proposals aimed at advancing biomedical research and development, with a focus on enhancing human performance. The program is critical for fostering innovation in science and technology, particularly in areas that support the Department of Defense's mission. The estimated total program funding is $10 million, with individual awards ranging from $750,000 to $50 million, and proposals are due by July 31, 2028. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)" aimed at advancing innovative research into the biological factors that influence individual responses to probiotics. This initiative seeks applications that will explore person-specific characteristics, such as genetics, microbiome composition, and lifestyle, to improve the effectiveness of probiotic interventions and address variability in human responses. The total project period is limited to four years, with a maximum budget of $350,000 in direct costs per year, and applications are expected to include a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity. Interested applicants can find more information and submission guidelines at the NIH website, with the application deadline set for June 2, 2027, and anticipated awards starting in June 2025. For inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.
    Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)" aimed at addressing sleep health disparities among underserved populations through non-pharmacological interventions. The initiative seeks to support research that examines sleep as a modifiable factor influencing health disparities, particularly focusing on populations such as Black/African American, Hispanic/Latino, and other socioeconomically disadvantaged communities. This funding opportunity encourages diverse research methodologies, including randomized controlled trials, to explore effective interventions while emphasizing collaboration with affected communities to ensure culturally relevant outcomes. Applications are due by September 7, 2027, and interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the announcement page at https://grants.nih.gov/grants/guide/pa-files/PAR-24-110.html.